Profund Advisors LLC Supernus Pharmaceuticals, Inc. Transaction History

Profund Advisors LLC

$2.67 Billion
Q4 2024

A detailed history of Profund Advisors LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 7,639 shares of SUPN stock, worth $239,711. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,639

Previous 10,586 27.84%

Holding current value

$239,711

Previous $330,000 16.36%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$31.89 - $37.83 $93,979 - $111,485	-2,947 Reduced 27.84%	7,639 $276,000
Q3 2024 Nov 13, 2024	SELL	$25.77 - $35.16 $15,668 - $21,377	-608 Reduced 5.43%	10,586 $330,000
Q2 2024 Aug 13, 2024	BUY	$25.99 - $33.85 $118,072 - $153,780	4,543 Added 68.31%	11,194 $299,000
Q1 2024 May 08, 2024	SELL	$27.11 - $35.17 $84,528 - $109,660	-3,118 Reduced 31.92%	6,651 $226,000
Q4 2023 Feb 14, 2024	BUY	$22.72 - $29.68 $2,476 - $3,235	109 Added 1.13%	9,769 $282,000
Q3 2023 Nov 13, 2023	BUY	$27.57 - $32.91 $40,086 - $47,851	1,454 Added 17.72%	9,660 $266,000
Q2 2023 Aug 10, 2023	SELL	$29.91 - $38.73 $11,425 - $14,794	-382 Reduced 4.45%	8,206 $246,000
Q1 2023 May 11, 2023	BUY	$34.93 - $42.03 $299,978 - $360,953	8,588 New	8,588 $311,000
Q1 2019 May 15, 2019	SELL	$32.77 - $41.99 $241,613 - $309,592	-7,373 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$30.84 - $49.51 $77,809 - $124,913	-2,523 Reduced 25.5%	7,373 $245,000
Q3 2018 Nov 13, 2018	SELL	$42.7 - $56.55 $60,377 - $79,961	-1,414 Reduced 12.5%	9,896 $498,000
Q2 2018 Aug 13, 2018	BUY	$44.1 - $59.85 $51,244 - $69,545	1,162 Added 11.45%	11,310 $677,000
Q1 2018 May 14, 2018	BUY	$37.15 - $46.9 $101,010 - $127,521	2,719 Added 36.6%	10,148 $465,000
Q4 2017 Feb 14, 2018	BUY	$36.4 - $42.6 $40,294 - $47,158	1,107 Added 17.51%	7,429 $296,000
Q3 2017 Nov 13, 2017	SELL	$36.75 - $49.65 $107,346 - $145,027	-2,921 Reduced 31.6%	6,322 $253,000
Q2 2017 Aug 11, 2017	BUY	N/A	9,243	9,243 $398,000

Others Institutions Holding SUPN

# of Institutions

303

Shares Held

60.7M

Call Options Held

22.3K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.68B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Supernus Pharmaceuticals, Inc. Transaction History